Leukine

Active Ingredient(s): Sargramostim, GM-CSF
FDA Approved: * March 5, 1991
Pharm Company: * BERLEX LABS
Category: Cancer

Sargramostim (tradename Leukine) is a recombinant granulocyte macrophage colony-stimulating factor (GM-CSF) that functions as an immunostimulator. Contents 1 Medical uses 2 Contraindications 3 Adverse effects 4 Pharmacology 5 Chemistry 6 History 7 References Medical uses Sargramostim is primarily used for myeloid reconstitution after autologous or allogeneic bone marrow transplantation. It is also used to treat neutropenia induced by chemotherapy during the treatment of acute myeloid l... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Leukine 250 ug/ml Intravenous; Subcutaneous Injection, Powder, for Solution

NDC: 0024-5843

Labeler:

Sanofi-aventis U.S. LLC

Leukine 500 ug/ml Intravenous; Subcutaneous Liquid

NDC: 0024-5844

Labeler:

Sanofi-aventis U.S. LLC

Leukine 250 ug/ml Intravenous; Subcutaneous Injection, Powder, for Solution

NDC: 58468-0180

Labeler:

Genzyme Corporation

Leukine 250 ug/ml Intravenous; Subcutaneous Injection, Powder, for Solution

NDC: 71837-5843

Labeler:

Partner Therapeutics, Inc

Leukine 500 ug/ml Intravenous; Subcutaneous Liquid

NDC: 71837-5844

Labeler:

Partner Therapeutics, Inc